In an international study led by UCLA, researchers have shown that giredestrant, a next-generation oral selective estrogen ...

The first-line standard of care for HR-positive/HER2-negative breast cancer is cyclin-dependent kinase (CDK)4/6 inhibitors ...

Among more than 4,000 patients with hormone receptor (HR)-positive disease, 3-year invasive disease-free survival (IDFS) ...

Adjuvant giredestrant significantly improved invasive DFS vs. standard-of-care endocrine therapy in patients with early-stage ...

Sacituzumab govitecan failed to extend PFS in patients with hormone receptor-positive, HER2-negative breast cancer following ...

Giredestrant significantly improved IDFS over SOC endocrine therapy, reducing the risk of invasive disease recurrence or ...

Dr Josef Köhrle, discusses with Lorna Rothery the urgent need for stronger actions to address the potential health risks posed by these chemicals ...

Endocrine disruptors can be found in food, beauty products, plastic bottles and more. But how harmful are they? (Photo: Getty Images) Your hormones help control different functions in your body and ...

Receiving neoadjuvant endocrine therapy enabled many postmenopausal patients with ER+, HER2- breast cancer to undergo breast-conserving surgery.

Hypoparathyroidism, a rare and chronic endocrine disease, is characterized by insufficient levels of parathyroid hormone (PTH ...

The Oman Summit for Diabetes & Endocrine Across the Lifespan 2025 began today in Muscat Governorate. The opening ceremony was ...